Position in MLEC
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$0
+$0 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
3.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
2 quarters on record
Common Shares in MLEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $27,730,196 across 51 Biotechnology names. MLEC ranks #51 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,732 | $7,814,556 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,893 | $1,803,901 | |
| 3 | RPRX |
Royalty Pharma plc
|
27,331 | $1,532,449 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
27,091 | $1,056,819 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
110,630 | $968,565 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
10,914 | $948,972 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
17,292 | $943,105 | |
| 8 | EXEL |
Exelixis, Inc.
|
15,533 | $845,150 |
No Holdings History
No holdings records found for this institution in MLEC.